Commonwealth Equity Services »

4d Molecular Therapeutics In shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $150k 20k 7.50

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In